Blood test to guide antibiotic decisions in the ICU
Part of Infections clinical trials.
This trial uses a new blood test (called BV test) to help doctors decide if antibiotics should be stopped or continued for ICU patients with suspected or confirmed infections. It aims to reduce unnecessary antibiotic use while keeping patients safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently in the intensive care unit (ICU)
- You started taking antibiotics within the last 3 days for a known or possible infection
- Your doctor is willing to consider the BV test result when deciding about your antibiotics
- You do not have a severely weakened immune system (for example, due to certain conditions or treatments)
- You do not have advanced cancer that has spread, or you are not receiving only comfort care
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device that measures antibiotic levels in blood quickly at the bedside, so doctors can adjust your dose to make sure it's effective. It may help ICU patients on beta-lactam antibiotics get the right amount.
This trial tests whether using a blood test called 'PCT' can help doctors decide when to start or stop antibiotics in critically ill adult patients in the EICU. The goal is to reduce unnecessary antibiotic use while still effectively treating bacterial infections.
This trial studies whether using the MeMed BV® blood test in the emergency room or urgent care can help doctors decide when antibiotics are (or are not) needed for suspected lung infections. It may help reduce unnecessary antibiotics while still treating infections when needed.
This trial tests whether reporting antibiotic sensitivity results in under 6 hours helps doctors choose the right β-lactam antibiotic faster for ICU patients with certain bloodstream infections. If you are in the ICU with a Gram-negative infection, your doctors will use a quick test to pick the best treatment.
This study monitors how antibiotics behave in the body for ICU patients being treated for sepsis or septic shock. It aims to learn whether better monitoring can support safer, more effective antibiotic use.
This study tests whether using a DNA test on lung fluid can help doctors choose better antibiotics for pneumonia in ICU patients with weakened immune systems. It may lead to more effective treatment and fewer side effects.
Hear when a new Intensive Care Unit (ICU) Admission trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.